Ding Xu

State University Of New York At Buffalo

$3,436,251

Attributed

$5,763,656

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $834.8K · FY2017–25

$1M$750K$500K$250K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$5,763,656 · 3

By mechanism

R01$5,763,656 · 3

Top collaborators

Jian None Liu9 shared
Rafal L Pawlinski4 shared

Others in their field

Other Emerging Leaders on “Recombinants”

Beth Baseler · Leidos Biomedical Research, Inc.$22,470,677
Gary Fanger · Rise Therapeutics, Llc$21,558,703
Jay Evans · University Of Montana$16,434,783
Michael-Christopher Keogh · Epicypher, Inc.$12,736,766
Wilton B Williams · Duke University$10,993,477
Leonard Freedman · Leidos Biomedical Research, Inc.$9,341,910

Research focus

RecombinantsCell SurfaceBindingOligosaccharidesPlayHeparitin SulfateStructureLeadMammalian CellMissionKnockout MiceIn VitroAffinityBinding SitesGlycosaminoglycansIn VivoBone ResorptionComplexDrug DevelopmentExtracellular MatrixBiologicalBoneAffectBiochemical